Course Title: CE 9. Sleep: A Silent Contributor to Cognitive Problems


Credit Hours: 1.5


Instructor(s) Mark S. Aloia, PhD


Sleep: A Silent Contributor
to Cognitive Problems

Abstract & Learning Objectives

Sleep is something experienced everyday by all of us. If perturbed, sleep can affect cognitive function in predictable ways. Sleep can also herald the onset of certain cognitive disorders, making knowledge of sleep and its effects on cognition important to any clinician. An exhaustive review of sleep and its related disorders that affect both adults and children would take at least a full day to review. We will, in this shorter period, review some of the highlights from the recent literature including the effects of sleep deprivation, sleep apnea, and occult sleep disorders on cognitive functioning. Neuropsychological test results and neuroimaging will be included.

Mark S. Aloia, PhD

Mark S. Aloia, PhD

Sr. Director, Global Clinical Research, Philips/Respironics
Associate Professor, National Jewish Health

By the end of this workshop, participants will be able to:

  1. Describe the most common sleep disorders and ways to assess for them in a clinical interview.
  2. Explain the role of sleep loss in cognitive functioning and incorporate this information in the context of neuropsychological evaluations.
  3. Identify the cognitive presentations and describe  mechanisms for cognitive dysfunction among the most frequent sleep disorders encountered by clinical neuropsychologists.
  4. Identify areas for future research in the study of sleep and cognition.

Click here to view 43rd Annual Meeting presenter and program planner disclosures.

Speaker Biography

Mark Aloia is Senior Director of Global Clinical Research for Philips Healthcare and Associate Professor of Medicine at National Jewish Health in Denver, CO. He has also been on the faculty at the University of Rochester and at Brown University as a prominent sleep researcher. Dr. Aloia has studied the neuropsychology of sleep and adherence to Positive Airway Pressure therapy for the past 20 years. His focus on behavioral methods to improve adherence to treatment has made significant contributions to the sleep and health psychology fields. His studies include a consistent focus on cognition and several include a focus on neuroimaging. Dr. Aloia has been NIH funded consistently since 2000 through his academic work, with over $15M in funding to date. He serves as an NIH grant reviewer and has published over 50 scientific papers in high quality journals. Dr. Aloia is also on the Editorial Boards of the journals Sleep, Health Psychology, and Behavioral Sleep Medicine.

His role with Philips came as a part of an acquisition of Respironics, Inc. in 2007. His team of researchers at Philips conducts over 100 clinical trials per year including regulatory trials, post-market studies, preference trials, and trials with academic partners. He has faced the challenge of conducting highly scientific clinical trials within the rapidly changing and time-constrained business environment.